Cyclacel pharmaceuticals, inc. (CYCC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Jun'10
Revenues:
Total revenues

-

-

-

0

-

150

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration and research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

277

205

222

139

424

462

296

512

247

735

356

396

299

309

264

212

-

38

26

-

-

Collaboration and research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

253

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

139

-

715

-

512

247

735

356

396

299

309

264

212

-

38

26

-

119

Operating expenses:
Cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

92

Research and development

1,106

1,430

1,063

1,153

1,012

1,142

1,205

1,182

798

745

958

1,222

1,312

1,932

2,409

2,637

2,499

2,556

2,904

2,580

4,342

4,416

4,972

4,545

4,344

2,491

4,575

2,631

1,580

1,996

1,532

1,717

1,347

1,322

General and administrative

1,318

1,363

1,285

1,184

1,192

1,474

1,250

1,283

1,364

1,452

1,154

1,267

1,381

1,514

1,273

1,345

1,384

1,726

1,205

1,333

1,468

1,613

1,433

1,386

1,462

1,782

1,529

1,787

2,683

2,663

2,028

2,121

1,768

3,091

Total operating expenses

2,424

-

2,348

-

2,204

-

2,455

-

-

-

-

-

-

-

-

-

-

-

-

-

5,810

6,029

6,405

5,931

5,806

4,273

6,104

4,418

4,263

4,659

3,560

3,838

3,115

4,505

Total operating expenses

-

-

-

2,337

-

-

-

2,465

2,162

2,197

2,112

2,489

2,693

-

3,682

3,982

3,883

-

4,109

3,913

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating loss

-2,424

-2,793

-2,348

-2,337

-2,204

-2,466

-2,455

-2,465

-2,162

-2,197

-2,112

-2,489

-2,693

-3,169

-3,477

-3,760

-3,744

-3,861

-3,394

-3,617

-5,298

-5,782

-5,670

-5,575

-5,410

-3,974

-5,795

-4,154

-4,051

-4,654

-3,522

-3,812

-3,115

-4,386

Other income (expense):
Change in valuation of financial instruments associated with stock purchase agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

27

4

20

227

4

64

47

-

-

0

-

-

-

-

-

-

Change in valuation of Economic Rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-570

50

63

-146

56

-

Change in valuation of liabilities measured at fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20

-

-

-

0

-

0

1

8

42

-

Change in valuation of warrants liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-273

Foreign exchange gains (losses)

69

-14

79

21

15

-48

1

-39

-4

26

-22

16

-59

-96

51

138

180

-14

219

-195

-378

13

10

-43

10

18

25

-101

120

55

6

117

114

-49

Interest income

28

47

42

56

79

93

85

84

69

58

30

18

12

6

8

13

10

4

2

2

1

1

3

1

1

1

8

3

1

5

5

6

6

8

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

Other income, net

817

-

53

170

-

50

0

66

566

42

28

0

879

10

18

18

20

-1

13

62

20

-

-

26

-

27

16

5,500

4

0

1

29

47

-

Total other income, net

914

41

174

247

94

95

86

111

631

126

36

34

832

-80

77

169

210

-11

207

-135

-377

-125

9

-60

-36

-52

49

5,402

695

-413

-50

306

153

223

Loss before taxes

-1,510

-

-2,174

-

-2,110

-

-2,369

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,675

-5,907

-5,661

-5,635

-5,446

-4,026

-5,746

1,248

-3,356

-5,067

-3,572

-3,506

-2,962

-4,163

Loss before taxes

-

-

-

-2,090

-

-

-

-2,354

-1,531

-

-2,076

-2,455

-1,861

-

-3,400

-3,591

-3,534

-

-3,187

-3,752

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-290

-448

-273

-307

-268

-352

-301

-502

-182

-200

-219

-268

-306

-410

-454

-626

-493

-498

-478

-405

-763

-1,108

-750

-816

-569

-452

-730

-230

-258

-637

-419

-127

-168

-230

Net loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,799

-4,911

-4,819

-4,877

-3,574

-5,016

1,478

-3,098

-4,430

-3,153

-3,379

-2,794

-

Income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

6

10

13

21

20

24

26

-

1,263

-198

-

-

Income tax on discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2

3

5

6

8

10

10

-

-

-

-

-

Net income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

4

7

8

15

12

14

16

-334

1,263

-198

-161

-

Net loss

-1,220

-2,304

-1,901

-1,783

-1,842

-2,019

-2,068

-1,852

-1,349

-1,871

-1,857

-2,187

-1,555

-2,839

-2,946

-2,965

-3,041

-3,374

-2,709

-3,347

-4,912

-4,799

-4,907

-4,812

-4,869

-3,559

-5,004

1,492

-3,082

-4,764

-1,890

-3,577

-2,955

-3,933

Dividend on convertible exchangeable preferred shares

50

-

50

-

50

-

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Dividend on convertible exchangeable preferred shares

-

-

-

50

-

-

-

50

50

-

50

50

50

50

50

50

50

-

50

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Beneficial conversion feature of Series A convertible stock

-

-

-

-

-

-

-

-

-

-

3,638

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

3,373

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common shareholders

-1,270

-2,355

-1,951

-1,833

-1,892

-2,070

-2,118

-1,902

-1,399

-2,086

-8,918

-2,237

-1,605

-

-2,996

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend on convertible exchangeable preferred shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

661

0

8,366

-

-

-

-

2,496

Dividend on convertible exchangeable preferred shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50

50

50

50

50

50

63

63

122

182

182

182

182

114

Net loss applicable to common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,015

-3,091

-3,425

-2,759

-3,397

-4,962

-4,849

-4,957

-4,862

-4,919

-3,609

-5,728

1,429

-11,570

-4,946

-2,072

-3,759

-3,137

-6,543

Basic and diluted earnings per common share:
Net loss per share, continuing operations - basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.20

-0.22

-0.22

-0.25

-

-0.32

-

-1.18

-

-0.40

-

-0.38

-

Net income per share, discontinued operations - basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

0.15

-

-0.02

-

Net income per share, discontinued operations - basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.00

-

0.00

-

-

-

-

-

-

-

Net loss per share - basic and diluted (in dollars per share)

-1.48

2.50

-0.11

-0.11

-2.77

-0.16

-0.18

-0.16

-0.12

-0.16

-0.91

-0.50

-0.38

-0.59

-0.86

-1.01

-1.04

-3.03

-0.95

-1.19

-0.19

-0.20

-0.22

-0.22

-0.25

-

-0.32

-

-1.18

-

-0.25

-

-0.40

-

Weighted average common shares outstanding - basic and diluted

859

30,205

17,199

17,199

681

12,384

11,997

11,997

11,997

11,983

9,835

4,434

4,271

4,260

3,473

3,000

2,965

-20,970

2,889

2,865

26,067

23,032

22,676

22,582

19,530

-

17,788

-

-

-

-

-

-

-

Net income (loss) per share, continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.10

-

-

-

-0.42

-

-

Net income (loss) per share, discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

-

-

-

-

Net (loss) income per share, discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.02

-

-

Net income (loss) per share applicable to common shareholders (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.10

-

-

-

-0.45

-

-0.18

Net income (loss) per share, continuing operations - Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.10

-

-

-

-0.42

-

-

Net income (loss) per share, discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

-

-

-

-

Net (loss) income per share, discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.02

-

-

Net income (loss) per share applicable to common shareholders (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.10

-

-

-

-0.45

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,885

9,790

8,486

8,429

8,428

7,823

36,565

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,927

-

-

-

8,428

-

-